Calcium supplementation on bone loss in postmenopausal women.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 14974070)

Published in Cochrane Database Syst Rev on January 01, 2004

Authors

B Shea, G Wells, A Cranney, N Zytaruk, V Robinson, L Griffith, C Hamel, Z Ortiz, J Peterson, J Adachi, P Tugwell, G Guyatt, Osteoporosis Methodology Group, Osteoporosis Research Advisory Group

Articles citing this

Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31

Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ (2006) 2.11

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79

Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res (2009) 1.66

Canadian Consensus Conference on osteoporosis, 2006 update. J Obstet Gynaecol Can (2006) 1.33

Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr (2008) 1.12

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int (2010) 0.97

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab (2008) 0.96

Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products. Osteoporos Int (2012) 0.96

Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions. Dialogues Clin Neurosci (2011) 0.94

The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates. J Bone Miner Res (2011) 0.91

The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag (2008) 0.87

The risks and benefits of calcium supplementation. Endocrinol Metab (Seoul) (2015) 0.79

Calcium intake and hip fracture risk: a meta-analysis of prospective cohort studies. Int J Clin Exp Med (2015) 0.77

Milk consumption throughout life and bone mineral content and density in elderly men and women. Osteoporos Int (2013) 0.77

Bone health nutrition issues in aging. Nutrients (2010) 0.77

Strontium Ranelate: Long-Term Efficacy against Vertebral, Nonvertebral and Hip Fractures in Patients with Postmenopausal Osteoporosis. Ther Adv Musculoskelet Dis (2010) 0.75

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging (2015) 0.75

Dietary calcium intake and calcium supplementation in hungarian patients with osteoporosis. Int J Endocrinol (2013) 0.75

Calcium intake and bone mineral density as an example of non-linearity and threshold analysis. Osteoporos Int (2015) 0.75

Prevalence and Risk Factors of Osteoporosis Among Jordanian Postmenopausal Women Attending the National Center for Diabetes, Endocrinology and Genetics in Jordan. Biores Open Access (2017) 0.75

Articles by these authors

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50

Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61

Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA (1998) 23.39

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

Alignment of whole genomes. Nucleic Acids Res (1999) 20.02

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature (1997) 19.08

A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20

Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 12.21

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials (1995) 9.85

A methodological framework for assessing health indices. J Chronic Dis (1985) 9.76

Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25

Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol (2002) 8.88

Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res (2000) 8.69

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16

Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11

Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science (1998) 7.96

Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA (1994) 7.85

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78

A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol (2000) 7.60

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Academic medicine and the pharmaceutical industry: a cautionary tale. CMAJ (1994) 6.98

Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97

Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med (1995) 6.23

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21

Effects of high levels of DNA adenine methylation on methyl-directed mismatch repair in Escherichia coli. Genetics (1983) 5.43

A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns (1998) 5.40

The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature (1998) 5.16

Problems in the handling of clinical and research evidence by medical practitioners. Arch Intern Med (1983) 5.16

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09

Prevalence of AIDS-related risk factors and condom use in the United States. Science (1992) 5.05

A critical appraisal of the efficacy of continuing medical education. JAMA (1984) 4.95

A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) (2003) 4.86

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81

Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73

Determining optimal therapy--randomized trials in individual patients. N Engl J Med (1986) 4.49

Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA (1994) 4.49

Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34

Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res (2003) 4.33

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16

Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group. JAMA (1995) 4.14

Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. BMJ (2002) 3.90

Microbial genes in the human genome: lateral transfer or gene loss? Science (2001) 3.87

HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA (1994) 3.80

The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75

Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med (1968) 3.72

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65

Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65

Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64

Validity and reliability of a questionnaire for measuring child oral-health-related quality of life. J Dent Res (2002) 3.59

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 3.45

Computer searching of the medical literature. An evaluation of MEDLINE searching systems. Ann Intern Med (1985) 3.45

Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45

CODIS STR loci data from 41 sample populations. J Forensic Sci (2001) 3.43

Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care (1996) 3.37

A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J Virol (1994) 3.32

A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations. JAMA (1997) 3.26

The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22

Raised ESR in polymyalgia rheumatica no longer a sine qua non? Lancet (1996) 3.20

Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making (1998) 3.18

The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13

Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) 3.00

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut (1999) 2.98

The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis (1985) 2.96

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci (2000) 2.87

The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85

The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res (2008) 2.81

Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol (1998) 2.77

Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75

Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum (2006) 2.73

Condom use in multi-ethnic neighborhoods of San Francisco: the population-based AMEN (AIDS in Multi-Ethnic Neighborhoods) Study. Am J Public Health (1992) 2.71

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med (1999) 2.69

Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med (1970) 2.69

Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev (2002) 2.65

Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58

Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ (1995) 2.58